Finzati - Logo
AVDL logo

Avadel Pharmaceuticals plc

AVDL • Drug Manufacturers - Specialty & Generic
$21.64
— 0.00 (0.00%)
Current price
EarningsLatest report: Sep 30, 2025
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$2.19B
Growth
4.2%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 43.3%Manageable debt level · 0.02Healthy liquidity · 2.75Weak profitability
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Nov 4, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$21.64
Change0.00%
Shares Out101.28M
Market Cap$2.19B
Enterprise Value$2.14B
52W Range6.38 - 23.57
Beta1.31
P/E-7,883.50
P/S8.82
P/B22.31
P/FCF61.90
EV/Sales8.59

Investment DNA

How strong this company looks for long-term investors

45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
37/100
Why this score▼
Positive revenue growth · 43.3%Manageable debt level · 0.02Healthy liquidity · 2.75Weak profitability

Analyst view

Analyst sentiment and price target

AVDL
Analyst sentiment
Based on 14 analyst votes · 2026-09-05
79/100
Bullish
Bullish
8
Hold
6
Bearish
0
Price Target
2026-06-06
Low
$18.50
Mean
$21.43
Median
$20.00
High
$30.00

Company Overview

IPO: 6/7/1996
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 22.31
Debt / Equity i: 0.02
Operating Margin: -25.07%
Net Margin: -28.87%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.02
Current Ratio: 2.75
Quick Ratio: 2.33
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 6 high-volume insider sells detected
Weiss Asset Management LP
Transaction: 02/13/2026
SELL
Change
-11,112,052
Price
$21.00
Filing
02/18/2026
Type
SELL
Weiss Asset Management LP
Transaction: 02/11/2026
OTHER
Change
0
Price
Not reported
Filing
02/18/2026
Type
OTHER
Amin Naseem
Transaction: 02/12/2026
SELL
Change
-11,000
Price
$10.83
Filing
02/12/2026
Type
SELL